Mondrian Investment Partners LTD Sells 2,373 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Mondrian Investment Partners LTD lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 229,711 shares of the healthcare conglomerate’s stock after selling 2,373 shares during the period. UnitedHealth Group makes up approximately 2.2% of Mondrian Investment Partners LTD’s investment portfolio, making the stock its 21st biggest holding. Mondrian Investment Partners LTD’s holdings in UnitedHealth Group were worth $124,616,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the company. Madison Investment Advisors LLC bought a new stake in UnitedHealth Group in the fourth quarter worth about $19,027,000. JPL Wealth Management LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $21,912,000. Phillips Financial Management LLC increased its position in shares of UnitedHealth Group by 10.9% during the fourth quarter. Phillips Financial Management LLC now owns 539 shares of the healthcare conglomerate’s stock worth $273,000 after acquiring an additional 53 shares during the period. Thompson Siegel & Walmsley LLC increased its position in shares of UnitedHealth Group by 68.0% during the fourth quarter. Thompson Siegel & Walmsley LLC now owns 2,424 shares of the healthcare conglomerate’s stock worth $1,226,000 after acquiring an additional 981 shares during the period. Finally, Impact Capital Partners LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $3,186,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $480.79 on Friday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a 50 day moving average price of $511.85 and a 200 day moving average price of $551.01. The firm has a market capitalization of $439.78 billion, a price-to-earnings ratio of 31.02, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $5.83 EPS. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be given a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.75%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

UNH has been the topic of a number of research reports. Piper Sandler reduced their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Truist Financial cut their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Barclays cut their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. Finally, HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a report on Friday, January 10th. Twenty equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.